http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2913687-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-24 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54393 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 |
filingDate | 2014-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_858cff64e4565e4022fafecfe00edbd2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd5cc5986b0bf0263010d1251dc03804 |
publicationDate | 2015-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CA-2913687-A1 |
titleOfInvention | Interference-suppressed immunoassay to detect anti-drug antibodies in serum samples |
abstract | Herein is reported a method for the detection of anti-drug antibodies against a drug which is an antibody, in a sample from a rheumatoid arthritis patient, the method comprising a capture drug antibody and a tracer drug antibody, each employed at the same concentration, at a concentration of 0.5 to 10 .MICRO.g/ml, wherein the sample is incubated simultaneously with the capture drug antibody and the tracer drug antibody for 1 to 16 hours, the capture drug antibody and the tracer drug antibody are derivatized via a single lysine residue, the sample comprises 1 % serum (v/v), oligomeric human IgG is added to the sample prior to the incubation with the capture drug antibody and the tracer drug antibody, and the capture drug antibody and the tracer drug antibody comprise monomeric biotin and digoxygenin respectively. |
priorityDate | 2013-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 67.